Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -28.88% is 72% above its 5-year average of -103.01%, near the high end of its 5-year range (-3926.13%–-25.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.75% above its 12-month average of -34.28%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -28.88%.
RETURN ON INVESTED CAPITAL (ROIC)
-28.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-34.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-50.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-103.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-79.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+15.75%
CURRENT VS 3Y AVG
+42.88%
CURRENT VS 5Y AVG
+71.97%
CURRENT VS 10Y AVG
+63.90%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 677 covered companies
CURRENT VS SECTOR MEDIAN
+15.32%
vs the sector median at left
Benitec Biopharma Inc.
Market Cap
$303.53M
Return on Invested Capital (ROIC)
-28.88%
TTM Avg
-34.28%
3Y Avg
-50.55%
5Y Avg
-103.01%
Market Cap
$297.62M
Return on Invested Capital (ROIC)
-136.49%
TTM Avg
-130.82%
3Y Avg
-85.38%
5Y Avg
-76.42%
Market Cap
$309.62M
Return on Invested Capital (ROIC)
-122.21%
TTM Avg
-122.21%
3Y Avg
-122.21%
5Y Avg
-122.21%
Market Cap
$290.97M
Return on Invested Capital (ROIC)
-14.06%
TTM Avg
-26.07%
3Y Avg
-28.37%
5Y Avg
-26.89%
Market Cap
$290.79M
Return on Invested Capital (ROIC)
-61.10%
TTM Avg
-38.45%
3Y Avg
-31.16%
5Y Avg
-81.63%
Market Cap
$289.25M
Return on Invested Capital (ROIC)
-49.76%
TTM Avg
-54.76%
3Y Avg
-73.23%
5Y Avg
-84.98%
Market Cap
$318.73M
Return on Invested Capital (ROIC)
-136.92%
TTM Avg
-105.47%
3Y Avg
-71.42%
5Y Avg
-55.10%
Market Cap
$285.94M
Return on Invested Capital (ROIC)
-129.90%
TTM Avg
-509.42%
3Y Avg
-303.54%
5Y Avg
-247.13%
Market Cap
$319.27M
Return on Invested Capital (ROIC)
-164.32%
TTM Avg
-159.25%
3Y Avg
-125.06%
5Y Avg
-125.06%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | $303.53M | -28.88% | -34.28% | -50.55% | -103.01% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | -136.49% | -130.82% | -85.38% | -76.42% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $309.62M | -122.21% | -122.21% | -122.21% | -122.21% |
| Standard BioTools Inc. (LAB)vs › | $290.97M | -14.06% | -26.07% | -28.37% | -26.89% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.79M | -61.10% | -38.45% | -31.16% | -81.63% |
| Abeona Therapeutics Inc. (ABEO)vs › | $289.25M | -49.76% | -54.76% | -73.23% | -84.98% |
| Avita Medical Inc. (RCEL)vs › | $318.73M | -136.92% | -105.47% | -71.42% | -55.10% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.94M | -129.90% | -509.42% | -303.54% | -247.13% |
| CapsoVision, Inc. (CV)vs › | $319.27M | -164.32% | -159.25% | -125.06% | -125.06% |
| C4 Therapeutics, Inc. (CCCC)vs › | $321.20M | -35.92% | -35.67% | -36.59% | -30.23% |
ROIC
-28.9%
ROE
-25.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -28.88% |
| 2026-03-31 | -25.36% |
| 2025-12-31 | -25.73% |
| 2025-09-30 | -48.70% |
| 2025-06-30 | -42.71% |
| 2025-03-31 | -38.17% |
| 2024-12-31 | -34.60% |
| 2024-09-30 | -34.89% |
| 2024-06-30 | -47.56% |
| 2024-03-31 | -185.88% |
| 2023-12-31 | -138.99% |
| 2023-09-30 | -90.48% |
| 2023-06-30 | -3926.13% |
| 2023-03-31 | -380.28% |
| 2022-12-31 | -195.28% |
| 2022-09-30 | -116.61% |
| 2022-06-30 | -518.89% |
| 2022-03-31 | -208.12% |
| 2021-12-31 | -150.03% |
| 2021-09-30 | -96.88% |
| 2021-06-30 | -67.95% |
| 2021-03-31 | -114.98% |
| 2020-12-31 | -74.45% |
| 2020-09-30 | -124.26% |
| 2020-06-30 | -79.34% |
| 2020-03-31 | -53.58% |
| 2019-12-31 | -59.76% |
| 2019-06-30 | 13.86% |
| 2018-12-31 | 18.10% |
| 2018-09-30 | -12.34% |
| 2018-06-30 | -75.04% |
| 2018-03-31 | -106.22% |
| 2017-12-31 | -89.96% |
| 2017-09-30 | -73.47% |
| 2017-06-30 | -71.22% |
| 2017-03-31 | -67.23% |
| 2016-12-31 | -102.87% |
| 2016-09-30 | -81.03% |
| 2016-06-30 | -148.95% |
| 2016-03-31 | -79.60% |
| 2015-12-31 | -104.67% |
| 2015-06-30 | -64.38% |
| 2014-12-31 | -39.50% |
| 2014-09-30 | -28.63% |
| 2014-06-30 | -32.14% |
| 2014-03-31 | -18.53% |
| 2013-12-31 | -69.91% |
| 2013-09-30 | -57.89% |
| 2013-06-30 | -12.20% |
